March 3, 2021 -- Dotmatics has signed a licensing deal that grants Compugen rights to its informatics software.
Under the multiyear agreement, Compugen scientists based at the company's research and development facility in Israel will have access to a single information management platform. The tools enable gathering, analyzing, and visualizing project data.
Compugen will have access to Dotmatics' software as a service (SaaS) technology including bioregister, inventory, studies notebook, and platform applications, which may contribute to identifying novel immuno-oncology drug targets and biomarkers.
Dotmatrics technology will replace Compugen's current laboratory information management system (LIMS) and electronic lab notebook (ELN).